Amundi Has $342,000 Position in Vir Biotechnology, Inc. (NASDAQ:VIR)
Amundi increased its position in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 224.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 46,614 shares of the company’s stock after acquiring an additional 32,241 shares during the quarter. Amundi’s holdings in Vir Biotechnology were worth $342,000 at the end of the most recent quarter. […]
Amundi increased its position in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 224.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 46,614 shares of the company’s stock after acquiring an additional 32,241 shares during the quarter. Amundi’s holdings in Vir Biotechnology were worth $342,000 at the end of the most recent quarter. […]
